House Dems: Exclusivity period on biologics shouldn't be in trade deals

08/8/2011 | Hill, The

The 12-year exclusivity period for biologic drugs should not be subject to negotiation in the ongoing Trans-Pacific Partnership talks, a group of House Democrats told President Barack Obama. "Were the TPP to ultimately contain a 12-year biologics exclusivity provision, it would impede the ability of Congress to achieve the Administration's proposed 7-year change without running afoul of U.S. trade obligations," the representatives wrote to Obama.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX